1435049 - Aduro Biotech, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ADRO (1435049)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-07-17
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$6.96-10,454206,215-5%-$72,803
D
2018-06-01
ADROIsaacs Stephen TPres, CEOM - OptEx$1.00+40,000214,678+23%+$40,000
D
2018-06-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$8.68-40,000214,678-16%-$347,004
2018-05-17
ADROTempleman BlaineGCS - Sale$8.15-2,00069,937-3%-$16,300
D
2018-05-09
ADROIsaacs Stephen TPres, CEOM - OptEx$0.97+40,000214,678+23%+$38,976
D
2018-05-09
ADROIsaacs Stephen TPres, CEOS - Sale+OE$8.01-40,000214,678-16%-$320,348
D
2018-04-02
ADROIsaacs Stephen TPres, CEOM - OptEx$0.82+40,000214,678+23%+$32,800
D
2018-04-02
ADROIsaacs Stephen TPres, CEOS - Sale+OE$8.91-40,000214,678-16%-$356,400
DM
2018-03-08
ADROIsaacs Stephen TPres, CEOM - OptEx$0.48+72,051214,678+51%+$34,700
DM
2018-03-08
ADROIsaacs Stephen TPres, CEOS - Sale+OE$8.48-72,051214,678-25%-$611,058
2018-02-26
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$6.48-6,874216,669-3%-$44,522
D
2018-01-25
ADROSchafer Gregory WCOOM - OptEx$0.82+60,000254,062+31%+$49,200
D
2018-01-25
ADROSchafer Gregory WCOOX - OptEx$0.013,317254,062-1%$33
D
2018-01-05
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+7,949214,678+4%+$3,577
D
2018-01-05
ADROIsaacs Stephen TPres, CEOS - Sale+OE$7.95-7,949214,678-4%-$63,195
D
2017-12-29
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$1.45+52,000124,603+72%+$75,400
DM
2017-12-29
ADROSchafer Gregory WCOOM - OptEx$0.89+62,000190,745+48%+$55,207
D
2018-01-02
ADROSchafer Gregory WCOOS - Sale+OE$7.61-20,000190,745-9%-$152,142
2017-12-18
ADROTempleman BlaineEVP, GCS - Sale$8.25-2,88469,937-4%-$23,793
2017-12-15
ADROIsaacs Stephen TPres, CEOG - Gift$0.00-74,100214,678-26%-$0
D
2017-12-15
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$1.45+64,10872,603+755%+$92,957
D
2017-12-15
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$8.11-65,22372,603-47%-$529,187
2017-12-11
ADROVan Elsas AndreaChief Scientific OfficerA - Grant$0.00+20,962223,543+10%+$0
A
2017-09-12
ADROVan Elsas AndreaChief Scientific OfficerA - Grant$0.00+27,975202,581+16%+$0
A
2017-09-13
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$10.99-4,922202,581-2%-$54,072
2017-12-11
ADROIsaacs Stephen TPres, CEOA - Grant$0.00+44,200288,778+18%+$0
2017-12-11
ADROSacks NatalieChief Medical OfficerA - Grant$0.00+16,31294,052+21%+$0
2017-12-11
ADROTempleman BlaineEVP, GCA - Grant$0.00+13,98772,821+24%+$0
2017-12-11
ADROLew JenniferSVP of FinanceA - Grant$0.00+11,65073,988+19%+$0
D
2017-12-01
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+10,00073,718+16%+$5,200
D
2017-12-01
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$9.40-10,00073,718-12%-$93,998
D
2017-12-01
ADROLew JenniferSVP of FinanceM - OptEx$0.82+6,60062,338+12%+$5,412
D
2017-12-01
ADROLew JenniferSVP of FinanceS - Sale+OE$9.46-6,60062,338-10%-$62,433
D
2017-12-01
ADROSchafer Gregory WCOOM - OptEx$1.04+20,000148,745+16%+$20,767
D
2017-12-01
ADROSchafer Gregory WCOOS - Sale+OE$9.34-20,000148,745-12%-$186,882
D
2017-12-01
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+40,000244,578+20%+$18,000
D
2017-12-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$9.38-40,000244,578-14%-$375,028
2017-11-17
ADROTempleman BlaineEVP, GCS - Sale$8.85-24358,8340%-$2,151
D
2017-11-15
ADROLew JenniferSVP of FinanceM - OptEx$0.82+6,60062,338+12%+$5,412
D
2017-11-15
ADROLew JenniferSVP of FinanceS - Sale+OE$8.95-6,60062,338-10%-$59,070
DM
2017-11-10
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+19,800244,578+9%+$8,910
DM
2017-11-10
ADROIsaacs Stephen TPres, CEOS - Sale+OE$7.97-19,800244,578-7%-$157,723
DM
2017-11-10
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+5,87773,718+9%+$3,056
DM
2017-11-10
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$8.00-5,87773,718-7%-$47,040
D
2017-11-06
ADROSchafer Gregory WCOOM - OptEx$1.04+20,000148,745+16%+$20,767
D
2017-11-06
ADROSchafer Gregory WCOOS - Sale+OE$7.97-20,000148,745-12%-$159,312
D
2017-11-06
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+4,12373,718+6%+$2,144
D
2017-11-06
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$8.04-4,12373,718-5%-$33,132
DM
2017-11-06
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+20,200244,578+9%+$9,090
DM
2017-11-06
ADROIsaacs Stephen TPres, CEOS - Sale+OE$7.98-20,200244,578-8%-$161,157
D
2017-10-02
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+10,00073,718+16%+$5,200
D
2017-10-02
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.59-10,00073,718-12%-$105,870
D
2017-10-02
ADROSchafer Gregory WCOOM - OptEx$1.36+20,000148,745+16%+$27,148
D
2017-10-02
ADROSchafer Gregory WCOOS - Sale+OE$10.75-20,000148,745-12%-$215,060
D
2017-10-02
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+40,000244,578+20%+$18,000
D
2017-10-02
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.78-40,000244,578-14%-$431,032
D
2017-10-02
ADROLew JenniferSVP of FinanceM - OptEx$0.82+6,60062,338+12%+$5,412
D
2017-10-02
ADROLew JenniferSVP of FinanceS - Sale+OE$10.61-6,60062,338-10%-$69,995
2017-09-18
ADROTempleman BlaineEVP, GCS - Sale$11.20-2,88458,834-5%-$32,301
2017-09-12
ADROIsaacs Stephen TPres, CEOA - Grant$0.00+82,100244,578+51%+$0
2017-09-13
ADROIsaacs Stephen TPres, CEOS - Sale$10.99-12,204244,578-5%-$134,071
2017-09-12
ADROSchafer Gregory WCOOA - Grant$0.00+32,625148,745+28%+$0
2017-09-13
ADROSchafer Gregory WCOOS - Sale$10.99-4,859148,745-3%-$53,380
2017-09-12
ADROSacks NatalieChief Medical OfficerA - Grant$0.00+32,62577,740+72%+$0
2017-09-12
ADROBrockstedt Dirk G.EVP of Research, Dev.A - Grant$0.00+27,97573,718+61%+$0
2017-09-13
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale$10.99-3,55773,718-5%-$39,076
2017-09-12
ADROLew JenniferSVP of FinanceA - Grant$0.00+23,30062,338+60%+$0
2017-09-13
ADROLew JenniferSVP of FinanceS - Sale$10.99-3,55762,338-5%-$39,076
2017-09-12
ADROVan Elsas AndreaChief Scientific OfficerA - Grant$0.00+32,625207,231+19%+$0
2017-09-13
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$10.99-4,922207,231-2%-$54,072
2017-09-12
ADROTempleman BlaineEVP, GCA - Grant$0.00+27,97561,718+83%+$0
2017-09-13
ADROTempleman BlaineEVP, GCS - Sale$10.99-3,55761,718-5%-$39,076
2017-09-01
ADROSacks NatalieChief Medical OfficerS - Sale$11.71-4,88545,115-10%-$57,196
D
2017-09-01
ADROSchafer Gregory WCOOM - OptEx$1.24+20,000120,979+20%+$24,800
D
2017-09-01
ADROSchafer Gregory WCOOS - Sale+OE$11.70-20,000120,979-14%-$233,980
D
2017-09-01
ADROLew JenniferSVP of FinanceM - OptEx$0.82+6,60042,595+18%+$5,412
D
2017-09-01
ADROLew JenniferSVP of FinanceS - Sale+OE$11.70-6,60042,595-13%-$77,242
D
2017-09-01
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+40,000174,682+30%+$18,000
D
2017-09-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.71-40,000174,682-19%-$468,596
D
2017-09-01
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+10,00049,300+25%+$5,200
D
2017-09-01
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.69-10,00049,300-17%-$116,948
DM
2017-08-10
ADRODubensky Thomas W.Chief Scientific OfficerM - OptEx$1.00+50,00039,900-495%+$50,000
DM
2017-08-10
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.38-50,00039,900-56%-$569,203
D
2017-08-07
ADROIsaacs Stephen TPres, CEOM - OptEx$0.45+40,000174,682+30%+$18,000
D
2017-08-07
ADROIsaacs Stephen TPres, CEOS - Sale+OE$12.19-40,000174,682-19%-$487,564
DM
2017-08-07
ADROSchafer Gregory WCOOM - OptEx$1.24+40,000120,979+49%+$49,620
DM
2017-08-07
ADROSchafer Gregory WCOOS - Sale+OE$12.17-40,000120,979-25%-$486,783
D
2017-08-07
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.52+10,00049,300+25%+$5,200
D
2017-08-07
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$12.18-10,00049,300-17%-$121,795
D
2017-08-07
ADROLew JenniferSVP of FinanceM - OptEx$0.82+6,60042,595+18%+$5,412
D
2017-08-07
ADROLew JenniferSVP of FinanceS - Sale+OE$12.17-6,60042,595-13%-$80,290
D
2017-07-03
ADROLew JenniferSVP of FinanceM - OptEx$0.82+12,00042,595+39%+$9,840
D
2017-07-03
ADROLew JenniferSVP of FinanceS - Sale+OE$11.14-12,00042,595-22%-$133,632
D
2017-07-03
ADROIsaacs Stephen TPres, CEOM - OptEx$0.50+40,000174,682+30%+$19,965
DM
2017-07-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.06-40,000174,682-19%-$442,397
D
2017-07-03
ADROBrockstedt Dirk G.EVP of Research, Dev.M - OptEx$0.48+10,00049,300+25%+$4,826
D
2017-07-03
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.02-10,00049,300-17%-$110,167
DM
2017-07-03
ADRODubensky Thomas W.Chief Scientific OfficerM - OptEx$0.52+50,00039,900-495%+$26,000
DM
2017-07-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.33-50,00039,900-56%-$566,638
D
2017-06-28
ADROLew JenniferSVP of FinanceM - OptEx$0.82+12,00042,595+39%+$9,840

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top